A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)
Public ClinicalTrials.gov record NCT02742441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 3 study (Study 310) has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.
Study identification
- NCT ID
- NCT02742441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 409 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2016 (Type not available)
- Primary completion
- Feb 27, 2017 (Actual)
- Completion
- Jun 16, 2017 (Actual)
- Last update posted
- Nov 14, 2018
2016 – 2017
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 14 | Fort Smith | Arkansas | 72916 | — |
| Site 01 | Hot Springs | Arkansas | 71913 | — |
| Site 17 | Encino | California | 91436 | — |
| Site 19 | Denver | Colorado | 80220 | — |
| Site 16 | Brandon | Florida | 33511 | — |
| Site 15 | Clearwater | Florida | 33756 | — |
| Site 20 | Miami Lakes | Florida | 33014 | — |
| Site 11 | North Miami Beach | Florida | 33162 | — |
| Site 12 | Pinellas Park | Florida | 33781 | — |
| Site 10 | Carmel | Indiana | 46032 | — |
| Site 06 | New Albany | Indiana | 47150 | — |
| Site 13 | Quincy | Massachusetts | 02169 | — |
| Site 07 | Ann Arbor | Michigan | 48103 | — |
| Site 02 | Saint Joseph | Missouri | 64506 | — |
| Site 08 | Wilmington | North Carolina | 28405 | — |
| Site 04 | Gahanna | Ohio | 43230 | — |
| Site 05 | Nashville | Tennessee | 37215 | — |
| Site 09 | Austin | Texas | 78746 | — |
| Site 18 | San Antonio | Texas | 78229 | — |
| Site 21 | Norfolk | Virginia | 23507 | — |
| Site 03 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02742441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 14, 2018 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02742441 live on ClinicalTrials.gov.